SEERSeer, Inc.

$101M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+171.4% YoY

Gross Profit

$708,00019.6% margin

Operating Income

-$23M-647.2% margin

Net Income

-$23M-630.1% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+9.3%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$16M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$516M

Total Liabilities

$44M

Stockholders' Equity

$472M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$1M	+171.4%
Gross Profit	$708,000	$188,000	+276.6%
Operating Income	-$23M	-$17M	-40.6%
Net Income	-$23M	-$17M	-37.3%

Revenue Segments

Product

$2M66%

Related Party

$1M31%

Service

$57,0002%

Grant

$50,0001%

SEER Q2 2022 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena